[Considerations on uses of newly developed anti-tuberculosis drugs for multi-drug resistant tuberculosis].
We, group of tuberculosis experts, made discussions over how to improve the quality of treatment of multidrug resistant tuberculosis using a newly developed anti-tuberculosis drug, and at the same time, how to prevent the disadvantages of the treated patients and also that of persons who would be infected with newly produced drug-resistant bacilli, by preventing the emergence of resistance to the new drug. A series of proposals are made.
Toru
T
Mori
Kenji
K
Ogawa
Eriko
E
Shigeto
Tadao
T
Shimao
Katsuhiro
K
Suzuki
Kazunari
K
Tsuyuguchi
Hideaki
H
Nagai
Tomoshige
T
Matsumoto
Satoshi
S
Mitarai
Takashi
T
Yoshiyama
D000995:Antitubercular Agents / Q000627:therapeutic use*; D015195:Drug Design; D006801:Humans; D018088:Tuberculosis, Multidrug-Resistant / Q000188:drug therapy*
D000995:Antitubercular Agents